The starting price needs a supply period and formulation.

We checked Curex’s public program and billing information on September 20, 2026. This review separates published terms from details that still require a personal quote; availability and offers can change.

The quick read

  • The starting price needs a supply period and formulation.
  • The page displays starting figures of $149 for semaglutide and $199 for tirzepatide, including prescription and medication. The readable price cards do not clearly attach a supply period or purchase term to those numbers. We therefore do not label them verified monthly all-in totals.
  • Which formulation and supply period does this price cover, and what are the next charge and cancellation cutoff?

The care model

Curex lists compounded semaglutide and tirzepatide as injections and as dissolving tablets. Its program page describes clinician review, prescription medication and delivery, with no separate membership fee. The tablet and injectable pathways should be treated as different formulations when evaluating evidence and the actual prescription.

Published price and what it covers

The page displays starting figures of $149 for semaglutide and $199 for tirzepatide, including prescription and medication. The readable price cards do not clearly attach a supply period or purchase term to those numbers. We therefore do not label them verified monthly all-in totals.

Compare the amount due today and the recurring charge over the same period. Include care, medication, laboratory work and shipping wherever they are separate. Our GLP-1 cost guide explains that calculation.

Renewal, cancellation and open questions

The program page promises a full refund if compounded semaglutide or tirzepatide is not prescribed. That eligibility provision does not explain refunds after medical approval or pharmacy processing. We could not read substantive terms at the linked legal endpoint, so the renewal and cancellation rules remain open.

What matters when comparing this service

A medication category is not enough to make two offers comparable. Ask the clinician to identify the formulation and dispensing pharmacy, and ask billing to identify the supply period. Evidence for an approved injection cannot simply be transferred to a compounded tablet dissolved under the tongue.

A question to take to the provider

Which formulation and supply period does this price cover, and what are the next charge and cancellation cutoff?

Ask who prescribes, which pharmacy dispenses, and how to contact the clinical team between appointments. Request the payment and cancellation terms in writing. Our provider verification guide can help you check those responsibilities before paying.

Evidence and another useful comparison

This is research into public offers, not a patient-experience review. We have not enrolled, received treatment or independently measured service quality. Compounded medicines are not FDA-approved, and evidence for an approved product does not automatically establish equivalent results for another formulation. Read our formulation guide and discuss suitability with a licensed clinician.

For another care or payment model, see our Strut Health review. You can also search the provider directory. The CoreAge Rx review covers our featured commercial partner; that placement does not establish clinical superiority.

Sources & reading notes

Public materials checked September 20, 2026. Provider pages establish advertised terms, not independent proof of outcomes or service quality. Clinical information is general and is not personal medical advice. No clinician review of this article is claimed.

  1. Curex — official program source
  2. FDA: concerns about unapproved GLP-1 drugs
  3. FDA BeSafeRx: online pharmacy information

How we research · How commercial placement works